Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
488 |
|
| Actual shortage: | 25 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 457 (94%) | |
Discontinuation Reports |
62 |
|
| To be discontinued: | 9 (15%) | |
| Discontinued: | 51 (82%) | |
| Reversed: | 2 (3%) | |
Late reports |
31 (6%) |
|
Overdue reports |
23 (68%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-11 | 2024-08-06 | 221857 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-07-04 | 2025-11-07 | 261865 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2025-09-10 | 2025-09-24 | 266909 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2023-02-28 | 2023-05-01 | 185682 |
| LOVASTATIN | 40MG | TABLET | Resolved | 2025-03-19 | 2025-05-01 | 253032 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2021-07-08 | 2021-07-14 | 142026 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2023-11-15 | 2024-01-31 | 210273 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2024-07-31 | 2024-09-05 | 234154 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2024-10-18 | 2024-12-11 | 240624 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2025-02-06 | 2025-03-19 | 249651 |
| MEFLOQUINE | 250MG | TABLET | Resolved | 2023-08-23 | 2023-09-14 | 202753 |
| MEGESTROL | 160MG | TABLET | Resolved | 2024-05-24 | 2025-04-04 | 228783 |
| MEGESTROL | 40MG | TABLET | Resolved | 2020-07-07 | 2020-07-24 | 119624 |
| MEGESTROL | 40MG | TABLET | Resolved | 2022-11-22 | 2022-11-29 | 175461 |
| MEGESTROL | 40MG | TABLET | Resolved | 2023-03-30 | 2023-08-23 | 188323 |
| MEGESTROL | 40MG | TABLET | Resolved | 2024-06-12 | 2025-04-04 | 230221 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
| CIMETIDINE | 600MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60376 |
| DIAZEPAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60417 |
| DIAZEPAM | 2MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60411 |
| DIAZEPAM | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60414 |
| AA-DILTIAZ | 30MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60429 |
| SULFATRIM DS | 800MG 160MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61039 |
| SULFATRIM | 400MG 80MG | TABLET | Discontinued | 2018-09-10 | 2018-11-09 | 61036 |
| AA-AMILZIDE | 50MG 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60166 |
| AA-ATENIDONE | 25MG 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4698 |
| AA-ATENIDONE | 25MG 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4702 |
| CIMETIDINE | 800MG | TABLET | Discontinued | 2017-03-13 | 2018-09-21 | 1061 |
| AA-FENO-MICRO | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60483 |
| AA-FENO-SUPER | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4710 |
| AA-FENO-SUPER | 160MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60486 |
| FENOFIBRATE | Discontinued | 2019-01-03 | 2019-01-03 | 70900 | ||
| LOVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60606 |
| AA-MEDROXY | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
| MINOCYCLINE | 100MG | CAPSULE | Discontinued | 2017-03-30 | 2018-02-05 | 4728 |
| MINOCYCLINE | 50MG | CAPSULE | Discontinued | 2017-03-30 | 2018-02-05 | 4731 |